Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 08/30/2024 | CALL | $190.00 | 810 | +766 | +1,740.91% |
| 07/26/2024 | PUT | $175.00 | 990 | +719 | +265.31% |
| 07/26/2024 | PUT | $180.00 | 729 | +674 | +1,225.45% |
| 07/26/2024 | PUT | $182.50 | 419 | +413 | +6,883.33% |
| 03/21/2025 | CALL | $190.00 | 675 | +307 | +83.42% |
| 09/06/2024 | CALL | $240.00 | 304 | +304 | |
| 09/20/2024 | CALL | $175.00 | 3,582 | -188 | -4.99% |
| 01/17/2025 | CALL | $185.00 | 3,538 | -221 | -5.88% |
| 07/26/2024 | CALL | $175.00 | 655 | -317 | -32.61% |
| 08/16/2024 | CALL | $190.00 | 2,417 | -443 | -15.49% |
| 07/26/2024 | CALL | $180.00 | 2,271 | -584 | -20.46% |
| 07/26/2024 | CALL | $182.50 | 1,670 | -1,478 | -46.95% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.05% | 53.76M | 7.26B |
| Vanguard 500 Index Fund | 2.32% | 40.88M | 5.52B |
| Fidelity 500 Index Fund | 1.10% | 19.39M | 2.62B |
| SPDR S&P 500 ETF Trust | 1.09% | 19.15M | 2.58B |
| American Mutual Fund Inc | 1.00% | 17.6M | 2.38B |
| iShares Core S&P 500 ETF | 0.89% | 15.78M | 2.13B |
| Vanguard Index-Value Index Fund | 0.87% | 15.28M | 2.06B |
| Capital Income Builder, Inc. | 0.84% | 14.87M | 2.01B |
| Select Sector SPDR Fund-Health Care | 0.81% | 14.36M | 1.94B |
| Washington Mutual Investors Fund | 0.75% | 13.22M | 1.78B |
What Lies in Store for Healthcare ETFs in Q2 Earnings? - Zacks Investment Research
07/24 10:34 am
Zacks Investment Research
Read moreAbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now? - The Motley Fool
07/22 10:41 am
The Motley Fool
Read more10 Best Dividend Growth Stocks to Buy and Hold Forever - The Motley Fool
07/21 10:30 am
The Motley Fool
Read moreGastroparesis Treatment Market Size Estimated to Rise at a - GlobeNewswire
07/19 11:36 am
GlobeNewswire Inc.
Read morePharma Stock Roundup: JNJ, NVS Q2 Earnings, RHHBY's Positive Obesity Pill Data - Zacks Investment Research
07/19 08:31 am
Zacks Investment Research
Read moreAbbVie Unusual Options Activity - Benzinga
07/17 01:01 pm
Benzinga
Read moreInflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire
07/15 11:02 am
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever - The Motley Fool
07/15 06:38 am
The Motley Fool
Read more3 Dividend Growth Stocks to Buy and Hold - The Motley Fool
07/14 06:30 am
The Motley Fool
Read moreAbbVie Unusual Options Activity - Benzinga
07/11 02:47 pm
Benzinga
Read moreAbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock? - Zacks Investment Research
07/11 09:32 am
Zacks Investment Research
Read moreNEXGEL projects increased revenue in upcoming quarters - Investing.com
07/08 04:17 pm
Investing.com
Read moreA Closer Look at AbbVie's Options Market Dynamics - AbbVie (NYSE:ABBV) - Benzinga
07/03 12:46 pm
Benzinga
Read moreGlobal Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewswire
07/03 01:00 am
GlobeNewswire Inc.
Read moreA Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts
07/02 02:00 pm
Benzinga
Read more2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
07/01 10:48 am
The Motley Fool
Read moreAbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
07/01 08:37 am
Zacks Investment Research
Read more3 Magnificent Stocks Retirees Can Buy and Hold Forever
07/01 06:50 am
The Motley Fool
Read moreMerck (MRK) Gets CHMP Nod for PAH Drug Winrevair in Europe
07/01 05:30 am
Zacks Investment Research
Read moreIf I Had To Retire With 10 Dividend Aristocrats, It Would Be These
06/30 10:35 am
Seeking Alpha
Read morePharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
06/28 09:13 am
Zacks Investment Research
Read moreAbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
06/28 08:51 am
Zacks Investment Research
Read moreIs Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
06/28 06:20 am
Zacks Investment Research
Read moreAbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
06/27 01:22 pm
Benzinga
Read moreFDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
06/27 11:03 am
Zacks Investment Research
Read moreMerck's (MRK) Lung Cancer Candidate Faces FDA Rejection
06/27 10:21 am
Zacks Investment Research
Read moreIs Trending Stock AbbVie Inc. (ABBV) a Buy Now?
06/27 09:00 am
Zacks Investment Research
Read moreShould Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?
06/27 06:20 am
Zacks Investment Research
Read moreCan AbbVie Stock Keep Outpacing the S&P 500?
06/27 05:30 am
The Motley Fool
Read moreAbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection
06/26 09:05 am
Zacks Investment Research
Read moreAbbVie (ABBV) Stock Dips While Market Gains: Key Facts
06/25 05:45 pm
Zacks Investment Research
Read moreIs Pacer US Cash Cows 100 ETF (COWZ) a Strong ETF Right Now?
06/25 06:20 am
Zacks Investment Research
Read more3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
06/25 04:31 am
The Motley Fool
Read moreHere's Why You Should Consider Buying Alvotech (ALVO) Stock
06/24 09:23 am
Zacks Investment Research
Read more3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
06/24 09:10 am
Zacks Investment Research
Read moreIf You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
06/24 08:30 am
Zacks Investment Research
Read morePfizer: Seriously Undervalued At Peak Pessimism
06/23 11:13 am
Seeking Alpha
Read morePharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
06/21 09:45 am
Zacks Investment Research
Read moreJ&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
06/21 08:49 am
Zacks Investment Research
Read more10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
06/20 08:41 am
The Motley Fool
Read moreWhy AbbVie (ABBV) is a Great Dividend Stock Right Now
06/19 11:45 am
Zacks Investment Research
Read moreHere's Why AbbVie (ABBV) is a Strong Momentum Stock
06/19 09:50 am
Zacks Investment Research
Read moreAbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
06/19 08:45 am
Zacks Investment Research
Read more2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
06/19 04:19 am
The Motley Fool
Read moreAbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
06/18 05:45 pm
Zacks Investment Research
Read moreMustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
06/18 10:22 am
Zacks Investment Research
Read more2 Dividend Stocks That Could Pay You for Life
06/16 08:30 am
The Motley Fool
Read morePharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
06/14 09:05 am
Zacks Investment Research
Read moreAbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
06/14 08:50 am
Zacks Investment Research
Read more